Although the German Federal Government legalized medical cannabis only in 2017, its approach to release licenses and the large demand created an attractive market for well-established medical cannabis companies.
The success of the German medical cannabis market has brought Cannovum AG to become the first publicly traded medical cannabis company in Germany. The fully licensed pharmaceutical wholesaler, importer, and manufacturer was listed on the Düsseldorf Stock Exchange in May 2021.
Such achievement represents a significant milestone for the medical cannabis market in Germany. Today, Germany represents the largest and the most profitable medical cannabis market in Europe.
– Read the entire article at Forbes.